Treatment of Tuberculous Pleurisy With Contezolid in a Child With Glucose-6-Phosphate Dehydrogenase Deficiency: The First Case Report.

IF 2.9 4区医学 Q3 IMMUNOLOGY

Pediatric Infectious Disease Journal Pub Date : 2024-09-01 Epub Date: 2024-04-24 DOI:10.1097/INF.0000000000004369

Shaolan Shi, Binbin Feng, Dan Li, Mingxia Sun, Qingling Gai, Meiying Lin

引用次数: 0

Abstract

This is the first reported case of a pediatric patient with tuberculous pleurisy and glucose-6-phosphate dehydrogenase deficiency treated with contezolid concomitantly with other antituberculous drugs. The patient responded well to treatment, and no adverse events were observed. These findings suggest that contezolid may be a potential therapeutic option for tuberculous pleurisy in children and adolescents with glucose-6-phosphate dehydrogenase deficiency.

查看原文本刊更多论文

用康特唑胺治疗葡萄糖-6-磷酸脱氢酶缺乏症患儿的结核性胸膜炎：首例病例报告。

这是首例报告的患有结核性胸膜炎和葡萄糖-6-磷酸脱氢酶缺乏症的儿童患者在使用其他抗结核药物的同时使用康替佐胺治疗的病例。患者对治疗反应良好，未出现不良反应。这些研究结果表明，对于患有葡萄糖-6-磷酸脱氢酶缺乏症的儿童和青少年结核性胸膜炎患者，可以选择使用珂替唑烷进行治疗。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Pediatric Infectious Disease Journal 医学-传染病学

CiteScore

6.30

自引率

2.80%

发文量

566

审稿时长

2-4 weeks

期刊介绍： The Pediatric Infectious Disease Journal® (PIDJ) is a complete, up-to-the-minute resource on infectious diseases in children. Through a mix of original studies, informative review articles, and unique case reports, PIDJ delivers the latest insights on combating disease in children — from state-of-the-art diagnostic techniques to the most effective drug therapies and other treatment protocols. It is a resource that can improve patient care and stimulate your personal research.